Pulmonary Artery Sarcoma vs Pulmonary Embolism: Critical CT and MRI Clues for Accurate Diagnosis
Primary Pulmonary Artery Sarcoma:
The Rare Vascular Malignancy That Mimics Pulmonary Embolism
Introduction
Among the most challenging diagnoses in thoracic imaging is the differentiation of a massive pulmonary embolism from a primary pulmonary artery sarcoma (PPAS). Although pulmonary embolism is encountered daily in emergency departments and radiology practices worldwide, PPAS remains one of the rarest vascular malignancies known in medicine.
The clinical significance of this distinction cannot be overstated.
Patients with PPAS are frequently misdiagnosed as having pulmonary thromboembolic disease and consequently receive anticoagulation therapy for weeks or months before the correct diagnosis is established. During this delay, the tumor continues to grow, infiltrate adjacent structures, and dramatically worsen prognosis.
The present case illustrates exactly such a scenario.
A 64-year-old man presented with progressive cough and dyspnea for one month. Initial CT angiography demonstrated a large occlusive filling defect involving the right pulmonary artery and extending into distal lobar branches, strongly suggesting acute pulmonary embolism.
However, subsequent imaging revealed a far more sinister diagnosis.
Patient Story: When a Pulmonary Embolism Was Not a Pulmonary Embolism
The patient initially presented with:
Persistent cough
Progressive dyspnea
No significant prior medical history
CT pulmonary angiography demonstrated:
[Figure 1]
Large occlusive filling defect within the right main pulmonary artery extending into:
Upper lobar artery
Middle lobar artery
Lower lobar artery
Interpretation: Initially compatible with a massive pulmonary embolism.
[Figure 2]
Peripheral wedge-shaped consolidative opacities in the right lung.
Interpretation: Pulmonary infarctions secondary to vascular obstruction.
[Figure 3]
Straightening of the interventricular septum.
Interpretation: Evidence of right ventricular pressure overload and right heart strain.
Clinical Background
Primary pulmonary artery sarcoma is an exceptionally rare malignant mesenchymal tumor arising from the intimal layer of the pulmonary artery.
Estimated incidence:
0.001–0.03% of all thoracic malignancies.
Most patients present between:
40–60 years
Slight female predominance
Common symptoms include:
Dyspnea
Hemoptysis
Chest pain
Cough
These symptoms overlap substantially with pulmonary embolism, explaining the frequent diagnostic delay.
Imaging Findings
CT Angiography
[Figure 4]
Occlusive right pulmonary artery filling defect.
Key Observation
The lesion occupies nearly the entire lumen.
Unlike thromboembolism, the lesion demonstrates:
Arterial expansion
Lobulated contours
Heterogeneous appearance
These characteristics should raise suspicion of a neoplastic process.
[Figure 5]
Calcific foci within the lesion.
Clinical Pearl: Calcification within a presumed pulmonary embolus strongly suggests chronic pathology or neoplasm rather than acute embolism.
[Figure 6]
Persistent obstructive mass despite intervention.
Mechanical thrombectomy and anticoagulation failed to resolve the lesion.
This represents a major red flag for an alternative diagnosis.
Follow-up CT Findings
Two months later:
[Figure 7]
Marked progression of right pulmonary artery filling defect.
[Figure 8]
Development of an extravascular soft tissue component.
[Figure 9]
Extension into the right upper lobe.
[Figure 10]
Large nodular obstructing mass.
[Figure 11]
Extravascular invasion.
These findings are incompatible with bland thrombus and strongly favor malignancy.
MRI Findings
MRI plays a pivotal role in distinguishing tumors from thrombus.
[Figure 12]
T1-weighted MRI
Increased signal intensity within the pulmonary artery mass.
[Figure 13]
T2 HASTE
Heterogeneous hyperintense signal.
[Figure 14]
Diffusion-weighted imaging and ADC
Restricted diffusion.
Most Important MRI Finding
Post-gadolinium enhancement.
Unlike bland thrombus, sarcoma exhibits:
Tumor vascularity
Neoangiogenesis
Contrast enhancement
MRI findings in this patient strongly favored pulmonary artery sarcoma over thromboembolism.
Differential Diagnosis
1. Massive Pulmonary Embolism
Shared Features
Pulmonary artery filling defect
Dyspnea
Right heart strain
Distinguishing Features
No enhancement
No extravascular extension
Typically decreases with anticoagulation
2. Primary Lung Cancer With Vascular Invasion
Possible but uncommon.
The tumor origin is the pulmonary parenchyma rather than the arterial intima.
3. Primary Pulmonary Artery Sarcoma
Most consistent diagnosis due to:
Progressive growth
Arterial expansion
MRI enhancement
Diffusion restriction
Extravascular invasion
Histologic confirmation
Pathology Correlation
CT-guided biopsy demonstrated:
Spindle-cell neoplasm consistent with primary pulmonary artery sarcoma.
Histologically, these tumors often exhibit:
Intimal sarcoma features
High mitotic activity
Pleomorphic spindle cells
Necrosis
AI Applications in Pulmonary Artery Sarcoma
Rare diseases represent one of the most promising frontiers for healthcare AI.
Computer Vision
Deep-learning systems can detect:
Pulmonary artery enlargement
Filling defects
Tumor morphology
Foundation Models
Multimodal foundation models integrate:
CT
MRI
Pathology
Clinical notes
to generate diagnostic hypotheses.
Clinical Decision Support Systems
AI can alert radiologists when:
Filling defect enlarges despite therapy
Arterial expansion is present
Enhancement is detected
These features can trigger PPAS alerts.
Enterprise Imaging Platforms
Integration with:
PACS
RIS
Cloud Healthcare Infrastructure
allows longitudinal assessment and automated comparison studies.
Diagnostic Workflow
Key Imaging Pearls
1. Pulmonary artery sarcoma frequently mimics PE.
2. Failure of anticoagulation should prompt reconsideration.
3. Pulmonary artery expansion favors the tumor.
4. Extravascular extension strongly favors malignancy.
5. Calcification is atypical for acute PE.
6. MRI enhancement is highly suggestive of a tumor.
7. Restricted diffusion supports a neoplasm.
8. Serial growth excludes bland thrombus.
9. Histology remains definitive.
10. Early diagnosis significantly impacts survival.
Future Perspectives
Over the next decade, thoracic imaging will increasingly rely on:
Foundation AI models
Radiomics
Digital pathology integration
Automated differential diagnosis
Predictive oncology systems
Future AI platforms may identify pulmonary artery sarcoma before radiologists recognize subtle imaging clues.
Conclusion
Primary pulmonary artery sarcoma remains one of the most important and dangerous mimics of pulmonary embolism. This case demonstrates how a seemingly straightforward pulmonary artery filling defect evolved into a biopsy-proven vascular malignancy.
The critical imaging clues included:
Progressive growth
Arterial expansion
Extravascular extension
MRI enhancement
Diffusion restriction
For radiologists, cardiothoracic imagers, and AI researchers, recognizing these features may dramatically alter patient outcomes and prevent potentially fatal diagnostic delays.
7. Figure Suggestions
Figure 15. Pulmonary Embolism vs Pulmonary Artery Sarcoma
Figure 16. AI-Assisted Thoracic Imaging Workflow
8. Key Takeaways
PPAS is an extremely rare vascular malignancy.
It is frequently mistaken for pulmonary embolism.
Progressive filling defects despite anticoagulation are suspicious.
MRI enhancement is the most important differentiating feature.
AI may improve earlier detection in future clinical workflows.
References
El-Sayed Ahmed MM et al. Pulmonary artery sarcoma mimicking pulmonary embolism. Tex Heart Inst J. 2014. DOI: 10.14503/THIJ-13-3798
Liu M et al. Multiparametric MRI in differentiating pulmonary artery sarcoma and pulmonary thromboembolism. Diagn Interv Radiol. 2017. DOI: 10.5152/dir.2016.15415
Yi CA et al. Computed tomography in pulmonary artery sarcoma. J Comput Assist Tomogr. 2004. DOI: 10.1097/00004728-200401000-00007
Comments
Post a Comment